Tom Van Flandern

To Michael

If conventional medicine doctors have concluded that they cannot offer a viable treatment, then obviously any combination of alternative therapies is warranted. I have been a patient of cancer, not a healer. And to put it mildly, my well of wisdom has run dry.

It is certainly not my position to advise someone on what he or she should do with the rest of his or life.

But I do hope that something will work. Only two persons have had a profound effect on my life. Ayn Rand and Tom Van Flandern.


Gregg Wilson

Hi Gregg and Michael,

Please contact Sanoviv, they have a very comprehensive program that includes traditional medicine and surgery. The key is to look at a total program that also reinforces the bodies natural curative powers and looks into target specific programs for killing the cancer cells. Dr. Wentz has built a state of the art facility and has spent his entire life working with human cell cultures and immunological responses to curing disease. Sanoviv Medical Institute has a toll free number and a great staff, I have met Dr. Wentz personally and if anyone knows what the state of the art for creating optimum human health I would have to say it would be Dr. Wentz. The patient support is beyond anything I have ever seen, with a bank of experts in their respective fields---take a look at their website and listen to the testimonies. Like I stated before, one of my wife's students mother at Haulalai Academy was told that she only had months to live and now her cancer is in remission. I have met the mother and talked with her about Sanoviv---She is very thankful. I can tell you this, if I or my family were sick with a life threatening disease I would immediately go to Sanoviv.

I hope also that something will work, my prayers go out to you and your family. John

Folks,
Thanks for all of your referrals and recommendations, we're looking at everything. While Tom's energy is low and he easily fatigues, he is reasonably comfortable, is in good spirits and remains in full control of his faculties. One request Tom has at the moment... if anyone out there has either direct or indirect experience with colon stents he'd love to hear from you.

I promised a quick overview of the history so here it is. On Nov 11 2008 Tom went first to a doctor and then the hospital complaining of nausea and intense abdominal pain. A CAT Scan revealed a fist sized tumor on Tom's colon, 2 marble sized tumors in his liver, numerous abnormal growths lining his abdominal wall and ascites (excess fluid in the abdominal lining). The colon tumor was completely obstructing Tom's bowel causing distension and a great deal of pain.

The doctors were very grim and at one point Tom was told that while 'miracles do happen' the outcome on his situation was '99.99+%' certain. His life expectancy was set at 2-4 months. Because of the growths lining his abdominal wall the cancer was deemed inoperable and radiation was ruled out. An ileostomy (a surgical procedure in which the small intestine is attached to the abdominal wall in order to bypass the large intestine) was schedule to relieve the bowel obstruction.

Prior to surgery a second CAT scan was taken to look at Tom's lungs. Over 100 blood clots were discovered, including a full saddle embolism. These clots made very it unlikely Tom would survive any surgery. The ileostomy was called off and Tom's life expectancy was downgraded to less than a week.

Over the next 2 days Tom's condition deteriorated rapidly. Raising the head of Tom's bed even 8 inches caused his blood pressure to drop and he became faint. Tom no longer had the strength to even hold a pen. Talking more than a minute completely exhausted him. He was in constant pain from his enormously bloated belly, his lips cracked and his tongue swelled from being unable to drink and his throat was raw from the tube removing excess fluids from his stomach. The constant pain and lack of energy finally eroded Tom's will to live. We were told Tom could go at any time. Friends and family came to say goodbye and Tom made a few farewell phone calls.

At this point one of Tom's colleagues suggested we explore use of Thrombolytics, a class of drugs used to dissolve blood clots in heart attack and stroke patients. We discussed this treatment and the potential risks with the hospital doctor. Thrombolytics had never been used to treat a cancer patient at this hospital, there was a 3% chance of brain hemorrhage and because the drug dissolves clots there was an indeterminable risk of causing abdominal bleed out at his tumors. However, given the situation the treatment seemed like the only remaining option with a reasonable chance of success. We asked that the drug be administered and the hospital agreed.

Shortly after the Thrombolytics were applied blood filled the tube pumping Tom's stomach. The pump was turned off in the hope that eliminating suction would reduce the bleeding. A very long night vigil followed. Tom awoke about 3AM and announced he had rediscovered his will to live! The next morning Tom's bowel became partially unblocked. He sat up and had his first drink in a week. A new CAT scan showed nearly complete resolution of the clots in Tom's lungs.

Tom's improvement over the next week was simply amazing. At the end of the week he walked out of the hospital and went home. He's spent a good deal of quality time with his family and even recorded a few videos. He's still bloated and partially obstructed and his energy varies from day to day. Tom is taking regular injections of Lovenox (a Low Molecular Weight Heparin) to keep the hypercoagulation caused by his cancer under control. Next week Tom hopes to have a colon stent placed to alleviate the remaining bowel obstruction, reduce his bloating and allow him to eat more. Assuming that goes well then we will then turn our full attention to addressing the cancer.

Well that's it for now. I'll continue to post updates here periodically. Thanks -Mike

Mike,

Thank you for the update. I knew Tom was a fighter. How coulld he be otherwise, given his chosen career path?

LB

Thanks Mike for letting us know the whole story, It must have been a very traumatic experience for all of you and I really appreciate the effort it must have taken you just to write all of this down.

And just as Larry said, Tom is a fighter for sure.

Dear all,

As a layman I do not wish to interfere inappropriately in what is a private matter at this point. However, I am in regular contact with an "alternative" mainstream cancer researcher of some standing, and I'd like to post a popular article followed by his personal observations without further comment in the hope that it contains clues that can be useful to someone at some point. Best wishes.


By Bill Sardi and Timothy Hubbell
October 2008


It works 100% of the time to eradicate cancer completely, and cancer does not recur even years later. That is how researchers describe the most convincing cancer cure ever announced.

The weekly injection of just 100 billionths of a gram of a harmless glyco-protein (a naturally-produced molecule with a sugar component and a protein component) activates the human immune system and cures cancer for good, according to human studies among breast cancer and colon cancer patients, producing complete remissions lasting 4 and 7 years respectively. This glyco-protein cure is totally without side effect but currently goes unused by cancer doctors.

Normal Gc protein (also called Vitamin-D binding protein) , an abundant glyco-protein found in human blood serum, becomes the molecular switch to activate macrophages when it is converted to its active form, called Gc macrophage activating factor (Gc-MAF). Gc protein is normally activated by conversion to Gc-MAF with the help of the B and T cells (bone marrow-made and thymus gland-made white blood cells). But, as researchers explain it themselves, cancer cells secrete an enzyme known as alpha-N-acetylgalactosaminidase (also called Nagalase) that completely blocks conversion of Gc protein to Gc-MAF, preventing tumor-cell killing by the macrophages. This is the way cancer cells escape detection and destruction, by disengaging the human immune system. This also leaves cancer patients prone to infections and many then succumb to pneumonia or other infections.

The once-weekly injection of minute amounts of Gc-MAF, just 100 nanograms (billionths of a gram), activates macrophages and allows the immune system to pursue cancer cells with vigor, sufficient to produce total long-term cures in humans.

Nobuto Yamamoto, director of the Division of Cancer Immunology and Molecular Biology, Socrates Institute for Therapeutic Immunology, Philadelphia, Pennsylvania, says this is "probably the most potent macrophage activating factor ever discovered."

Once a sufficient number of activated macrophages are produced, another Gc-MAF injection is not needed for a week because macrophages have a half-life of about six days. After 16-22 weekly doses of Gc-MAF the amount of Nagalase enzyme fell to levels found in healthy people, which serves as evidence tumors have been completely eliminated. The treatment was fool-proof - - - it worked in 100% of 16 breast cancer patients and there were no recurrent tumors over a period of 4 years, says a report in the January 15 issue of the International Journal of Cancer. [International Journal Cancer.2008 January15; 122(2):461-7]

In another startling follow-up report by Dr. Yamamoto and colleagues, published in the upcoming July issue of Cancer Immunology Immunotherapy, Gc-MAF therapy totally abolished tumors in 8 colon cancer patients who had already undergone surgery but still exhibited circulating cancer cells (metastases). After 32-50 weekly injections, "all colorectal cancer patients exhibited healthy control levels of the serum Nagalase activity, indicating eradication of metastatic tumor cells,"said researchers, an effect that lasted 7 years with no indication of cancer recurrence either by enzyme activity or CT scans, said researchers. [Cancer Immunology, Immunotherapy Volume 57, Number 7 / July 2008] Published in an early online edition of this journal, this confirming report has received no attention by the new media so far, despite its striking importance.

Gc-MAF treatment for cancer has been agonizingly slow to develop. Dr. Yamamoto first described this immuno-therapy in 1993. [The Journal of Immunology, 1993 151 (5); 2794-2802]

In a similar animal experiment published in 2003, researchers in Germany, Japan and the United States collaborated to successfully demonstrate that after they had injected macrophage activating factor (Gc-MAF) into tumor-bearing mice, it totally eradicated tumors. [Neoplasia 2003 January; 5(1): 3240]

In 1997 Dr. Yamamoto injected GcMAF protein into tumor-bearing mice, with the same startling results. A single enzyme injection doubled the survival of these mice and just four enzyme injections increased survival by 6-fold. [Cancer Research 1997 Jun 1; 57(11):2187-92]

In 1996 Dr. Yamamoto reported that all 52 cancer patients he had studied carried elevated blood plasma levels of the immune inactivating alpha-N-acetylgalactosaminidase enzyme (Nagalase), whereas healthy humans had very low levels of this enzyme. [Cancer Research 1996 Jun 15; 56(12):2827-31]

In the early 1990s, Dr. Yamamoto first described how the human immune system is disengaged by enzymes secreted from cancer cells, even filing a patent on the proposed therapy. [US Patent 5326749, July 1994; Cancer Research 1996 June 15; 56: 2827-31]

Activated Gc protein has been used in humans at much higher doses without side effect. This Gc macrophage activating factor (Gc-MAF) has been shown to be effective against a variety of cancers including breast, prostate, stomach, liver, lung, uterus, ovary, brain, skin, head/neck cancer, and leukemia.

Although GcMAF is also called Vitamin-D binding protein, the activation of macrophages does not require Vitamin D.

It cannot be said the Gc-MAF cancer cure has gone unheralded. Reuters News covered this developing story in January. But the news story still did not receive top billing nor did it fully elucidate the importance of the discovery, actually made years ago, that the human body is capable of abolishing cancer once its immune system is properly activated.

GcMAF is a naturally made molecule and is not patentable, though its manufacturing process is patent protected. There is no evidence of any current effort to commercialize this therapy or put it into practice. Should such an effective treatment for cancer come into common practice, the income stream from health-insurance plans for every oncology office and cancer center in the world Would likely be reduced to the point of financial insolvency and hundreds of thousands of jobs would be eliminated.

The National Cancer Institute estimates cancer care in the U.S. costs ~$72 billion annually (2004). Furthermore, about $55 billion of cancer drugs are used annually, none which have not significantly improved survival rates throughout the history of their use. If a typical cancer patient had to undergo 30 GcMAF injections at a cost of $150 per injection, that would cost ~$4500, not counting doctor's office visits and follow-up testing. For comparison, gene-targeted cancer drugs range from $13,000 to $100,000 in cost per year and produce only marginal improvements in survival (weeks to months). [Targeted Oncology 2007 April, 2 (2); 113-19]

Up to this point, the National Cancer Institute is totally silent on this discovery and there is no evidence the cancer care industry plans to quickly mobilize to use this otherwise harmless treatment.

Addendum: Sadly, the treatment you have just read about is not available anywhere. Its inventor is attempting to patent a version of it to profiteer off of it even though there is no need to improve upon the GcMAF molecule - - it worked without failure to completely cure four different types of cancer with no long-term remissions and without side effect. While GcMAF is produced by every healthy adult, there are no centers available to extract it from blood samples and inject it into patients with malignancies. Hopefully, someday, doctors will write protocols to do this and submit them to institutional review boards so GcMAF treatment can be performed on an experimental basis. GcMAF is a naturally-made molecule that cannot be patented. This article was written to reveal that there are proven cancer cures that go unused. Of interest, not one oncologist has requested information about GcMAF since this article was written, while I have been barraged with inquires from cancer patients, their families and some interested physicians who are not cancer doctors.
-Bill Sardi

---

Dr. Andrew Maniotis' comment (via Email thus the at times informal tone and less than perfect punctuation and syntax):


Dear Claus, Sam,

Again, and consistent with my experience, experiments, and arguments, the experiments and human trial successes using GcMAF, and perhaps a wide array of other similar non-toxic glyco-protein molecules may also show in the future if this approach is ever allowed to be pursued by the cancer establishment, it may all be due to the fact that the "poison" injections disrupt the tumor biofil(s) microenvironment created and controlled by these molecules, and at the same time activate the toll receptors buried in the slime so that "a danger signal" is received by the body, and the
trapped inflammation can be seen by the immune system and rejected.

Moreover, the reactions to micro-quantitities of GcMAF described here are at a minimum reminiscent of the approaches Wilhelm Busch and Coley had first described independently and published as anecdotal reports describing their tumor rejection patients and their successes, the ignored experiments that Yarkoni and Rapp had shown years ago at the NCI using things such as squalene and mineral oil which are vaccine adjuvants that caused nearly 100% tumor rejection in hamsters and other animals, and which also paradoxically induced autoimmune diseases when injected
directly into the bloodstreams of experimental animals or Gulf War I
veterans who tested positive for squalene after the squalene-containing anthrax (or "HIV") vaccine experiments on them were conducted (pushed forward once again by our friend Edmond Tremont-see Gary Motsumoto's book, Vaccine A). The approach and chemical nature of this molecule is consistent with what we have found by defining, describing, and exploiting the vasculogenic mimicry tumor biofilm as I have called it, in the reversions of breast cancer and melanomas.

That this class of simple glyco-protein molecules, that fibronectin,
laminin, and antibodies against them all have such potential, that
bacteria bind to fibronectin, that toll receptors associate with toxins of micro-organisms- all suggest that Nature operates by using Her efficient tissue-building materials and designs in a plethora of different contexts as diverse as microbial biofilm mats, embryonic tissue building and its consequent ability to block any and all implanted tumors despite the most deranged aneuploidy or mutation, in the experiments of breast cancer or melanoma reversion and killing using antibodies against the gel-binding domain of fibronectin (to get rid of the gas fueling the tumor) or with excess laminin (which acts as a break and stops tumor growth), or as in
these elegant experiments described here by Bill Sardi and Timothy
Hubbell.

Alas, 'tis a pity to keep toxically poisoning or radiating patients, as has been going on for a century. But Ewing at Sloan Kettering with his foot on Coley's neck, supported by John D. Rockefeller and the greed of the fledgling radium industry, and due to the myopia of allopathic "killing" approaches that have been supported ever increasingly by the industrial power of the American petrochemical and pharmaceutical greed and control of our national cancer
foundations (ACS and NCI-who were not even allowed to vote on The Clean Air Act because of the power of the
cancer funding influences), there is little hope that things will change soon. Even some of the grant program administrators of the NCI I've talked to are aware of these issues, but nobody in the U.S. can change the practice of these increasingly toxic, multiple cocktail approaches that are so lucrative to the petrochemical and pharmaceutical giants that continue to pollute our world, generate cancers, and then provide toxic "cures" for them that will never work, and which never made any sense in the first place. I've been working with Sam Epstein and his organization, Stop Cancer Before It Starts, and was a signer of his book of that same name a few years ago. In it, is a breathtaking compilation of the conflicts of interests and corporate stakeholders who continue to impede
the implementation of the approaches shown here
( www.preventcancer.com/ ). The book is free and available on the Internet. . .